Experimental substantiation of fucoidan used as hepatoprotective drug in case of non-alcoholic fatty liver disease

27 April 2011
Written by Bivalkevich N.V., Karaman Yu.K.

  UDK: 616.36‑003.826‑085.244:615.322:582.272 | Pages: 41–43 | Read full textDownload PDF 


The paper describes effect from fucoidan on the histological liver structure, lipid blood spectrum, ‘lipid peroxidation–antioxidant defence’ system in rats with diet‑induced non‑alcoholic fat‑ty liver disease, and identifies hepatoprotective, hypo‑
lipidemic and detoxication properties of fu‑coidan that appear to be substantiated for applying in case of non‑alcoholic fatty liver disease.

Links to authors:

N.V. Bivalkevich, Yu.K. Karaman
Vladivostok Branch of the Far Eastern Scientific Centre of Physiology and Pathology of Breathing of the Siberian Branch of RAMS – Research Institute of Medical Climatology and Restorative Treatment (73g Russkaya St. Vladivostok, 690105 Russian Federation)

  1. Novgorodceva T.P., Jendakova Je.A., Jankova V.I. The manual of
    the methods research for parameters of the «lipid peroxidation‑
    antioxidant protection» system in biological fluids. Vladivostok:
    Izd‑vo Dalnevost. un‑ta, 2003. 80 p.
    2. Patent no. 2394281 The method of modeling for non‑alcoholic
    steatohepatitis. Karaman Ju.K., Novgorodceva T.P., Bivalkevich
    N.V., Lobanova E.G. Publicated 10.07.2010. Bjulleten No. 19.
    3. Pirs Je. Histochemistry [Gistohimija]. M.: Inostr. literatura, 1962.
    967 p.
    4. Shulpekova U.O. Nonalcoholic fatty liver disease: pathogen‑
    esis, diagnosis, treatment, Farmateka. 2007. Vol. 141, No. 6. P.
    5. Wekina M.I. Nonalcoholic fatty liver disease, Consilium medicum.
    2009. Vol. 11, No. 8, P. 37–39.
    6. Choi E., Kim A., Kim Y., Hwang J. Immunomodulating activity of
    arabinogalactan and fucoidan in vitro, J. Med. Food. 2005. Vol. 4,
    No. 8. P. 446–453.
    7. Matsumoto S., Nagaoka M., Hara T. et al. Fucoidan derived from
    Cladosiphon okamuranus Tokida ameliorates murine chronic
    colitis through the down‑regulation of interleukin‑6 produc‑
    tion on colonic epithelial cells, Clin. Exp. Immunol. 2004. Vol. 3,
    No. 136. P. 432–439.
    8. Perez‑Aguilar F. Etiopathogenesis of non‑alcoholic steatohepatitis,
    Gastroenterol. Hepatol. 2005. Vol. 7, No. 28. P. 396–406.
    9. Trappoliere M. The treatment of NAFLD, Eur. Rev. Med. Pharmacol. Sci. 2005. Vol. 5, No. 9. P. 299–304.
    10. Wang J., Zhang Q., Zhang Z., Li Z. Antioxidant activity of sulfated
    polysaccharide fractions extracted from Laminaria japonica, J.
    Biol. Macromol. 2008 Vol. 2, No. 42. P. 127–132.
    11. Zaporozhets, T.S., Kuznetsova, T.A., Smolina, T.P., Shevchen‑
    ko N.M. Immunotropic and anticoagulant activity of fucoidan
    from brown seaweed Fucus evanescens: prospects of application
    in medicine, J. Microbiol. 2006. No. 3. P. 54‑58.


Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.